Biosynex SA
PAR:ALBIO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Biosynex SA
Revenue
Biosynex SA
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biosynex SA
PAR:ALBIO
|
Revenue
€93.1m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
24%
|
CAGR 10-Years
48%
|
|
Edap Tms SA
NASDAQ:EDAP
|
Revenue
€60.4m
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
Biomerieux SA
PAR:BIM
|
Revenue
€3.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Carmat SA
PAR:ALCAR
|
Revenue
€2.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Biocorp Production SA
PAR:ALCOR
|
Revenue
€11.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Revenue
€104m
|
CAGR 3-Years
7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Biosynex SA's Revenue?
Revenue
93.1m
EUR
Based on the financial report for Dec 31, 2023, Biosynex SA's Revenue amounts to 93.1m EUR.
What is Biosynex SA's Revenue growth rate?
Revenue CAGR 10Y
48%
Over the last year, the Revenue growth was -53%. The average annual Revenue growth rates for Biosynex SA have been -15% over the past three years , 24% over the past five years , and 48% over the past ten years .